HB1739 would create an All Payor Claims Database (APCD) within Pennsylvania’s Health Care Cost Containment Council. The bill directs the council to collect, validate, analyze, and publish health care claims data from a broad set of payors and providers, including private insurers, third-party administrators, Medicaid, CHIP, Medicare-related coverage, certain public employee plans, providers, and facilities. The stated purpose is to improve transparency in health care pricing and quality, support consumer shopping for care, and give regulators better tools to study spending, utilization, outcomes, disparities, and market trends.
The APCD would require detailed claims submissions covering medical, mental health, dental, substance use disorder, emergency services, pharmaceuticals, durable medical equipment, and related provider and facility information. The bill also requires data on demographics, episode of care, diagnosis codes, insurance product type, billed and allowed amounts, out-of-pocket costs, utilization, and medication adherence. The council would be responsible for issuing public reports and maintaining databases that are accessible, machine-readable, mobile-friendly, multilingual where feasible, and useful for independent research and consumer comparison shopping.
HB1739 would significantly affect state administrative practice by assigning the Health Care Cost Containment Council new operational duties and giving the Insurance Department, Department of Health, Department of State, Department of Human Services, Department of Drug and Alcohol Programs, Department of Aging, and the Attorney General enforcement roles. It also creates a new funding requirement, including a minimum $4 million appropriation to establish the database, and authorizes ongoing appropriations for operations. The bill adds confidentiality protections for identifiable data, limits public disclosure to de-identified information, and establishes penalties for unauthorized disclosure or noncompliance, including daily administrative fines and broader civil and licensing consequences.
The overall sentiment reflected in the bill text is strongly supportive of transparency, consumer access, and data-driven oversight of health care costs. The findings section frames the APCD as a tool to help consumers understand prices and out-of-pocket costs before receiving care, while also helping regulators monitor insurance markets and health system spending. No committee transcript or vote history was provided, so there is no recorded public debate in the supplied materials to indicate support or opposition beyond the bill’s policy design.
The main points of contention likely involve the scope of mandatory data reporting, the breadth of entities covered, privacy and confidentiality concerns, and the cost of building and maintaining the system. The bill reaches many payors and providers, including government programs and certain federally linked plans to the extent allowed by federal law, which could raise implementation and preemption questions. It also imposes substantial penalties for noncompliance and requires detailed claims data submission, which may be viewed by insurers, administrators, and providers as administratively burdensome even as supporters see it as necessary for meaningful transparency.
The bill would amend Title 35 by adding a new chapter establishing an APCD and expanding the statutory duties of the Health Care Cost Containment Council. It would require data collection from a wide range of payors and providers, create public reporting and research databases, impose confidentiality rules, and authorize enforcement by multiple state agencies. It also appropriates at least $4 million for startup costs and sets out ongoing funding, vendor contracting, technical guidance, and penalty provisions that would affect insurers, third-party administrators, providers, facilities, and certain public coverage programs.
Based on the bill text, the measure is presented as a consumer- and regulator-focused health care transparency initiative, with a clear policy preference for better pricing, quality, and spending data. The sponsors and findings suggest a favorable view of APCDs as tools for market oversight and informed consumer choice. Because no committee discussion or vote record was provided, there is no direct evidence of opposition or support from debate; however, the structure of the bill suggests that likely support would come from transparency and health policy advocates, while likely concerns would come from payors, providers, and privacy-focused stakeholders.
The most notable areas of contention are likely to be data privacy, administrative burden, and the cost of implementation. The bill requires extensive claims reporting from insurers, administrators, providers, and facilities, including sensitive information about diagnoses, utilization, payments, and demographics, while also creating strict confidentiality rules and criminal penalties for unauthorized disclosure. Another likely point of dispute is the reach of the reporting mandate into Medicare, Medicaid, CHIP, FEHB, military coverage, self-funded plans, and other arrangements, which may raise federal-law and operational concerns. The required appropriation and ongoing funding obligations may also be debated, especially by fiscal conservatives or stakeholders concerned about the cost of maintaining the database.